Waterloo, Ontario - DALSA Corporation (TSX:DSA) today announced that it has signed a definitive agreement to sell assets for production and support of select legacy x-ray sensitive camera products that were manufactured and serviced at the Company’s Colorado Spring operations to Echoserve Inc. of Golden, Colorado. The deal is expected to close on April 4, 2008. Upon closing of the sale, DALSA will have substantially completed the divestiture of its operations in Colorado Springs.
Echoserve, a leading field service company and repair depot for diagnostic ultrasound, mammography and patient monitoring equipment, will transfer the equipment and inventory related to the select legacy x-ray products to their facility in Golden, Colorado and will provide continuing production and support there.
DALSA announced it intention to divest its Colorado Springs operations in September 2007. Since that time, the Company has successfully transferred its industrial products and strategic x-ray imaging products previously produced in Colorado Springs to its other locations.
About DALSA Corporation
DALSA is an international leader in high performance digital imaging and semiconductors with approximately 1000 employees world-wide. Established in 1980, the company designs, develops, manufactures, and markets digital imaging products and solutions, in addition to providing semiconductor products and services. DALSA's core competencies are in specialized integrated circuit and electronics technology, software, and highly engineered semiconductor wafer processing. Products and services include image sensor components (CCD and CMOS); electronic digital cameras; vision processors; image processing software; and semiconductor wafer foundry services for use in MEMS, high-voltage semiconductors, image sensors and mixed-signal CMOS chips. DALSA is listed on the Toronto Stock Exchange under the symbol “DSA” and has its corporate offices in Waterloo, Ontario, Canada.
For more information, please contact:
Vice President, Corporate Communications
Tel: (519) 886-6001 Ext. 2177
Fax: (519) 886-3972
Some of the statements in this presentation, including those relating to the company’s strategies and other statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, or similar expressions, are forward-looking statements within the meaning of securities law. Actual results may differ materially from those currently anticipated. Investors are cautioned that such forward-looking statements involve risks and uncertainties. Important factors that could cause actual results to differ materially from those expressed or implied by such forward looking statements are detailed from time to time in DALSA’s periodic reports filed with the Ontario Securities Commission and other regulatory authorities. Investors should read review the Business Risks and Prospects sections of the DALSA 2007 annual Management’s Discussion and Analysis (“MD&A”) to understand the assumptions, risks and uncertainties inherent in forward looking information or statements. DALSA has no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.